Adrenal gland pheochromocytoma is a rare tumor that forms in the adrenal glands and releases bursts of stress hormones, which can cause episodes of pounding headaches, rapid heartbeat, sweating, paleness, anxiety, and spikes in blood pressure that may come and go. Many people first hear about adrenal gland pheochromocytoma when sudden high blood pressure appears in someone who previously had normal readings. It can occur at any age but is most often found in adults, and while most tumors are noncancerous and treatable, untreated hormone surges can lead to complications like heart rhythm problems, stroke, or heart failure. Doctors typically confirm the diagnosis with blood or urine tests for excess hormones and imaging scans, and the main treatment is surgical removal, often after medications are used to safely control blood pressure and heart rate. Most people do well after surgery, though follow-up is important because the condition can rarely return or, in a minority, be linked to inherited syndromes.
How many people live with Adrenal gland pheochromocytoma?
Worldwide, as of 2020, about 78,000 people are thought to be living with pheochromocytoma and paraganglioma (a related tumor that grows outside the adrenal gland); adrenal gland pheochromocytomas make up about 80–85% of that group, which suggests roughly 62,000–66,000 people worldwide have adrenal gland pheochromocytoma—an estimate, not a direct count. In the United States in 2020, the same approach points to about 3,300 people with these tumors overall, with roughly 2,600–2,800 of them having an adrenal gland pheochromocytoma.
Overview
Adrenal gland pheochromocytomaSymptoms
Adrenal gland pheochromocytoma often causes sudden spells: pounding headache, heavy sweating, palpitations, and sharply high blood pressure. People may also feel anxiety, tremor, chest or abdominal pain, shortness of breath, or nausea, sometimes triggered by stress, surgery, or certain medicines.
Outlook and prognosis
Most people with adrenal gland pheochromocytoma do well after timely surgery and careful blood pressure control. Regular follow-up is key because tumors can recur or, less often, be cancerous. Genetic testing can guide lifelong screening plans for you and family members.
Causes and risk factors
Adrenal gland pheochromocytoma usually arises from gene changes in tumor cells, with about 30–40% linked to inherited syndromes (MEN2, VHL, NF1). Risk is higher with a family history. No proven lifestyle or environmental causes.
Genetic influences
Genetics play a major role in adrenal gland pheochromocytoma. About one-third to one-half arise from inherited variants, often in genes like RET, VHL, NF1, and SDHx. Genetic testing is recommended, even without a family history, to guide care and screening.
Diagnosis
The diagnosis of adrenal gland pheochromocytoma starts with measuring metanephrines in blood or urine. If elevated, doctors confirm with imaging such as CT or MRI; sometimes MIBG or PET scans and genetic testing are used.
Treatment and drugs
Treatment for adrenal gland pheochromocytoma centers on safely lowering high catecholamine effects before removing the tumor. Doctors typically use alpha-blockers (sometimes with beta-blockers) to steady blood pressure and heart rate, plus salt and fluids to prevent dips. When stable, minimally invasive surgery removes the adrenal tumor; genetic testing and long‑term follow‑up help guide care and check for recurrence.
Symptoms
Adrenal gland pheochromocytoma can cause sudden surges of stress hormones that raise blood pressure and make the heart race. Early symptoms of adrenal gland pheochromocytoma may look like brief panic-like spells with pounding headaches, sweating, and shakiness after stress or exercise. Symptoms vary from person to person and can change over time. Some people have constant high blood pressure; others have normal readings between episodes.
With adrenal gland pheochromocytoma, blood pressure can shoot up during a spell and sometimes stays high all the time. Headaches, blurry vision, or nosebleeds may come with spikes.
Sudden, throbbing head pain often builds quickly during an episode. This is common in adrenal gland pheochromocytoma and usually eases as your heart rate and pressure settle.
The heart may race, pound, or feel like it is skipping beats. These palpitations are a frequent sign of adrenal gland pheochromocytoma.
Intense sweating can appear out of the blue. It is a classic symptom during adrenal gland pheochromocytoma surges.
How people usually first notice Adrenal gland pheochromocytoma?
Many people first notice adrenal gland pheochromocytoma when sudden “spells” hit: pounding headaches, a racing or irregular heartbeat, sweating, shaking, and pale or flushed skin, often with severe anxiety or a sense of doom. These episodes can come in bursts lasting minutes to an hour, sometimes triggered by stress, physical exertion, surgery, certain medications, or even going to the bathroom, and blood pressure may spike very high between or during attacks. For some, the first signs of adrenal gland pheochromocytoma are difficult-to-control hypertension or a tumor found incidentally on an imaging scan done for another reason.
Types of Adrenal gland pheochromocytoma
Pheochromocytoma can look different from person to person, and doctors recognize a few clear variants that help explain differences in symptoms and timing. Some tumors are driven by inherited gene changes, while others arise sporadically. Symptoms don’t always look the same for everyone. Knowing the main variants can make the types of adrenal gland pheochromocytoma easier to understand and discuss with your care team.
Sporadic pheochromocytoma
These occur without a known inherited gene change. They often appear in mid-adulthood and typically involve just one adrenal gland. Symptoms may include sudden headaches, pounding heartbeat, sweating, and blood pressure spikes.
Hereditary syndromic
These are linked to inherited conditions such as MEN2, VHL, NF1, or SDHx-related syndromes. They can appear earlier in life, sometimes involve both adrenal glands, and may come with other tumor types tied to the underlying syndrome. Family history and genetic testing often guide diagnosis and follow-up.
Unilateral adrenal
The tumor is in one adrenal gland. Blood pressure surges, palpitations, and anxiety-like episodes can vary from rare to frequent. Removing the affected gland often improves symptoms.
Bilateral adrenal
Tumors involve both adrenal glands. People may have more intense or frequent episodes and need careful hormone and blood pressure management. Treatment planning often aims to preserve some adrenal function if possible.
Extra-adrenal paraganglioma
The tumor arises outside the adrenal glands in similar nerve tissue. Symptoms can be similar to adrenal pheochromocytoma, but location may alter how pressure or pain is felt. Imaging helps pinpoint the site for surgery.
Epinephrine-predominant
The tumor mainly releases adrenaline. People may feel tremor, palpitations, anxiety, and sudden spikes in blood pressure. Episodes can be triggered by stress, certain medicines, or even surgery.
Norepinephrine-predominant
The tumor mainly releases noradrenaline. This often causes sustained high blood pressure with spells of headache and sweating. Some may notice paler skin and cold hands during episodes.
Dopamine-predominant
The tumor mostly releases dopamine, which is less common. Symptoms can be milder or atypical, sometimes with less obvious blood pressure spikes. Testing for multiple catecholamines helps catch this variant.
Biochemical silent
The tumor produces little to no measurable hormone. People may have minimal symptoms, and the mass is sometimes found incidentally on imaging. Careful lab testing and specialized scans help confirm the diagnosis.
Metastatic or malignant
The tumor has spread beyond the original site, often to bone, liver, or lungs. Symptoms can include more persistent high blood pressure, weight loss, or pain related to spread. Management focuses on hormone control and treating the sites of spread.
Pediatric-onset
Pheochromocytoma appears in childhood or adolescence. These are more often hereditary and may be bilateral. Early recognition and genetic counseling are important for families.
Pregnancy-associated
Symptoms may surface or worsen during pregnancy. High blood pressure that does not respond as expected can be a clue. Early detection and careful planning reduce risks for the parent and baby.
Can I slow down the onset of symptoms?
No—there’s no strong evidence that diet, exercise, or other lifestyle steps can delay when symptoms from an adrenal gland tumor called pheochromocytoma first appear, because the tumor’s growth and hormone release are not driven by lifestyle. If you have a known inherited risk, expert guidelines recommend regular screening with blood or urine tests for adrenal hormone by-products and targeted scans starting at certain ages to find tumors early, which can lower the chance of sudden, dangerous symptoms but does not prevent the tumor itself. While this can feel frustrating, staying connected with a specialist team and following a screening plan can help catch problems early and keep you safe.
What genetics can tell you about symptoms
Certain inherited changes in genes like RET, VHL, NF1, SDHB, and SDHD can trigger adrenal pheochromocytomas that release too much adrenaline-like hormones. This often causes spells of pounding headaches, rapid heartbeat, sweating, paleness, tremor, and sudden high blood pressure.
Causes and risk factors
Most cases arise without a clear cause, but about a third are tied to inherited gene changes, so a family history or certain syndromes can raise risk. Adrenal gland pheochromocytoma is more likely in people with multiple endocrine neoplasia type 2, von Hippel–Lindau disease, neurofibromatosis type 1, or inherited changes in SDH genes, and these inherited forms often appear at a younger age or affect both adrenal glands. There are no proven lifestyle or environmental triggers, and it can occur in adults of any sex, though it most often shows up between ages 20 and 50. Doctors distinguish between risk factors you can change and those you can’t; for this condition, most fall into the “can’t change” group, so knowing your family history and considering genetic counseling can be helpful if there’s concern. If a close relative has one of these syndromes or a paraganglioma, ask your clinician about the genetic causes of adrenal gland pheochromocytoma and whether monitoring or testing is appropriate.
What are the most common causes or risk factors?
Most adrenal gland pheochromocytomas happen by chance with no clear cause. The strongest known risk is an inherited gene change or family history—often as part of conditions like multiple endocrine neoplasia type 2, von Hippel-Lindau disease, neurofibromatosis type 1, or certain changes in SDH genes—and about one third of cases are linked to these. Risk is also higher when someone is diagnosed at a younger age, has tumors in both adrenal glands, or has related tumors called paragangliomas.
Environmental and biological risk factors
Adrenal gland pheochromocytoma is uncommon, and many only hear about it when testing starts for sudden spikes in blood pressure or fast heartbeats. If you’re reading about early symptoms of adrenal gland pheochromocytoma, it can also help to know what might raise the chance of it developing. Doctors often group risks into internal (biological) and external (environmental). For this condition, internal body factors seem to play a larger role, while clear links to outside exposures are limited.
Adrenal gland pheochromocytoma is diagnosed most often between ages 30 and 50. It can appear earlier or later, but likelihood peaks in this window. Age itself does not cause it; it reflects when these tumors tend to emerge.
Changes in the hormone‑making cells of the inner adrenal gland (medulla) can lead to tumor growth. Disrupted signals that control cell growth and oxygen response raise the chance of a pheochromocytoma forming. These are internal, body‑based factors.
Long-standing low oxygen from cyanotic heart disease or very high altitude has stronger links to similar tumors outside the adrenal gland (paragangliomas). Any connection with adrenal gland pheochromocytoma is less certain and, if present, likely small. Current evidence remains limited.
No specific chemical, radiation, or pollution exposure has been firmly proven to cause adrenal gland pheochromocytoma. Research so far has not identified a consistent environmental trigger. Guidance may change if future studies find clear links.
Genetic risk factors
Genetic changes play a major role in adrenal gland pheochromocytoma, with many cases linked to inherited syndromes or single‑gene variants. Having a family history or a known gene change raises lifetime risk, and tumors may appear at a younger age or in both adrenal glands in hereditary forms. Carrying a genetic change doesn’t guarantee the condition will appear. In high‑risk families, genetic counseling and testing can clarify personal risk before early symptoms of adrenal gland pheochromocytoma arise.
Autosomal dominance: A single altered copy of certain genes can raise risk of adrenal gland pheochromocytoma. This pattern can pass from an affected parent to a child, but not everyone who inherits the change develops a tumor.
RET (MEN2): Changes in the RET gene cause multiple endocrine neoplasia type 2, which strongly raises adrenal gland pheochromocytoma risk. Tumors may occur in both adrenal glands and often appear earlier in life.
VHL gene: Inherited VHL variants increase the chance of pheochromocytoma along with other features doctors screen for. Onset is often younger than in unrelated (sporadic) cases.
NF1 gene: People living with neurofibromatosis type 1 have higher pheochromocytoma risk than the general population. Typical features include skin spots and benign nerve tumors, and sudden blood pressure spikes can be a clue.
SDHB gene: This gene change raises the chance of adrenal gland pheochromocytoma and paraganglioma and carries a higher risk of spread. Regular, lifelong surveillance is usually advised.
SDHD imprinting: Risk is highest when the variant is inherited from the father, due to a parent‑of‑origin effect. Tumors often occur in the head and neck, but adrenal pheochromocytoma can also happen.
Other SDHx genes: Variants in SDHC, SDHA, or SDHAF2 are less common causes with variable risk levels. Age at diagnosis and tumor location can differ between families.
TMEM127 gene: Inherited changes mainly lead to adrenal gland pheochromocytomas, sometimes affecting both glands. Risk of spread appears lower than with SDHB‑related tumors.
MAX gene: This gene is linked to bilateral adrenal tumors and multiple tumors across a lifetime. Some families show stronger effects when the change is inherited from the father.
FH gene: Rare changes in this gene, also tied to a kidney‑tumor syndrome, can raise pheochromocytoma or paraganglioma risk. Skin bumps and kidney findings may appear in affected families.
EPAS1 (HIF2A): Activating changes can cause adrenal or extra‑adrenal tumors, including adrenal gland pheochromocytoma, and may be associated with high red blood cell counts. Many cases are mosaic, meaning not all cells carry the change.
Mosaicism: When only some cells carry a gene change, adrenal gland pheochromocytoma can develop even without a clear family history. This can also reduce the chance of passing the change to children.
De novo variants: A gene change can arise for the first time in someone with no family history. Their children can still inherit the risk in an autosomal dominant pattern.
Lifestyle risk factors
Day to day, certain habits don’t cause adrenal gland pheochromocytoma, but they can set off episodes—sudden pounding heartbeat, severe headache, sweating, or sharp jumps in blood pressure. Many living with adrenal gland pheochromocytoma notice flares around stress, intense exertion, or particular foods and drinks. Below are practical, lifestyle risk factors for Adrenal gland pheochromocytoma that may trigger symptoms or make them harder to control. Some risks can be shifted through habits, others remain fixed—doctors call these ‘modifiable’ and ‘non-modifiable.’
Sudden heavy lifting or high-intensity workouts can trigger adrenaline release and sharp blood pressure spikes in people with adrenal gland pheochromocytoma. Favor steady, moderate activity and get medical clearance for any training changes. Warm-ups and gentle cool-downs can reduce swings.
Acute stress, conflict, or anxiety can provoke hormone surges and symptom flares. Stress-management routines like paced breathing or short mindfulness breaks may ease the peaks. Consistent sleep and regular routines help buffer daily stress.
Coffee, strong tea, energy drinks, and nicotine can raise heart rate and blood pressure. For many with adrenal gland pheochromocytoma, cutting back or avoiding stimulants lowers the chance of sudden spells. Decaf choices and nicotine cessation support can help.
Alcohol may trigger headaches, palpitations, or blood pressure swings. Some people are sensitive even to small amounts, so a cautious approach or avoidance is reasonable. Discuss limits with your care team if you notice flares after drinking.
Risk prevention
Adrenal gland pheochromocytoma can’t usually be prevented outright, but you can lower risks tied to dangerous blood pressure spikes and catch problems early. For people with a family history or a known gene change, planned screening and, in rare cases, preventive surgery may be options. Prevention is about lowering risk, not eliminating it completely. Knowing early symptoms of adrenal gland pheochromocytoma—sudden pounding heartbeat, strong headaches, and heavy sweating—can help you act quickly.
Ask about genetic counseling and testing if pheochromocytoma runs in your family or you have syndromes like MEN2, VHL, or SDHx. Finding a gene change allows tailored screening and, in select cases, preventive steps.
People at higher risk may need periodic blood or urine tests and imaging to spot tumors early. Early detection lowers the chance of severe blood pressure crises from adrenal gland pheochromocytoma.
Some medicines and substances can trigger dangerous surges, including decongestants, certain antidepressants (MAOIs), stimulants, and cocaine. Check with your doctor before starting new medications or supplements.
Keep blood pressure in a healthy range with lifestyle steps and medications if prescribed. Good control reduces strain on the heart and lowers the chance of complications if pheochromocytoma is present.
Can you prevent Adrenal gland pheochromocytoma?
There’s no proven way to prevent adrenal gland pheochromocytoma. If it runs in your family or you have a known inherited gene change, genetic counseling and regular checkups can help find it early and guide care to reduce complications. Healthy lifestyle steps are good for overall health, but they haven’t been shown to stop this tumor from forming.
Transmission
Adrenal gland pheochromocytoma is not contagious—you can’t catch it or pass it like a cold. Instead, it sometimes runs in families because of a single gene change inherited in an autosomal dominant way; if a parent carries the gene change, each child has a 50% chance of inheriting it. Many cases happen with no family history due to a new mutation or a tumor that isn’t linked to inherited genes. If you’re diagnosed, a genetics team can explain how adrenal gland pheochromocytoma is inherited and whether relatives should consider testing. This is about genetic transmission of adrenal gland pheochromocytoma, not infection.
When to test your genes
Consider genetic testing if you were diagnosed with pheochromocytoma at a young age, have multiple or bilateral adrenal tumors, a paraganglioma, or a family history of these tumors or related syndromes (like MEN2, VHL, NF1, or SDHx). Test before surgery when possible to guide care. First‑degree relatives may also benefit.
Diagnosis
Episodes of pounding heartbeat, headaches, sweating, and spikes in blood pressure often prompt a check for adrenal gland pheochromocytoma. The diagnosis of adrenal gland pheochromocytoma usually starts with reviewing symptoms and blood pressure patterns, then confirming with lab tests and imaging. Doctors usually begin with blood and urine tests that look for the hormone byproducts this tumor releases, then order scans to find its location.
Providers look for very high readings, sudden surges, or large swings between visits. Some people also have drops in pressure when standing, which can cause lightheadedness.
A blood test measures metanephrines, the stable breakdown products of adrenaline-like hormones. High levels strongly suggest pheochromocytoma, especially when drawn after resting quietly.
A full-day urine collection checks fractionated metanephrines and catecholamines. Proper collection timing improves accuracy and helps confirm abnormal blood results.
Certain medicines, caffeine, nicotine, and stress can boost levels and confuse results. Your provider may adjust timing or advise brief pauses when safe to improve test clarity.
How is Adrenal gland pheochromocytoma diagnosed?
Doctors usually start with blood tests and a 24-hour urine collection to look for high levels of adrenaline-type hormones and their breakdown products; this is the key step in confirming the condition. If these are raised, imaging scans such as CT or MRI are used to find and size the tumor, and in some cases a special tracer scan is added when the tumor is hard to spot or may be outside the adrenal gland. Because some pheochromocytomas run in families, genetic testing may be recommended after diagnosis, especially for those with a family history, more than one tumor, or very early onset.
Stages of Adrenal gland pheochromocytoma
Adrenal gland pheochromocytoma does not have defined progression stages. Because the tumor’s behavior varies and symptoms often come in bursts—such as early symptoms of adrenal gland pheochromocytoma like pounding headaches, a racing heartbeat, and sweating—clinicians usually describe it as either confined to the adrenal gland or metastatic (spread) rather than using stepwise stages. Different tests may be suggested to help confirm the diagnosis and check whether it has spread, including blood or urine hormone measurements and scans such as CT or MRI. Ongoing monitoring typically includes blood pressure checks and repeat hormone tests, with imaging if results or symptoms change.
Outlook and prognosis
Daily life with adrenal gland pheochromocytoma depends a lot on whether the tumor is found early, whether it has spread, and how well blood pressure and adrenaline surges are controlled. Many people ask, “What does this mean for my future?”, especially if they’ve had scary episodes like pounding headaches, palpitations, or spikes in blood pressure while shopping or climbing stairs. After surgery to remove a benign tumor, most people see blood pressure improve and symptoms settle within days to weeks. When tumors are cancerous or can’t be fully removed, doctors focus on controlling hormone release, lowering cardiovascular risks, and tracking for spread with scans and lab tests.
Doctors call this the prognosis—a medical word for likely outcomes. For localized, noncancerous adrenal gland pheochromocytoma, long‑term survival is excellent, but there is a lifelong chance of recurrence in the adrenal area or elsewhere, so regular follow‑up matters. If the tumor is malignant or has spread, outlook varies; some respond well for years to treatments such as targeted medicines, radiopharmaceuticals, or repeat surgeries, while others have more aggressive disease. Death is uncommon after successful removal of a benign tumor, but malignant pheochromocytoma can shorten life expectancy, mainly due to metastases or complications from uncontrolled blood pressure and heart strain.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Inherited syndromes can raise the chance of multiple tumors or earlier recurrence, so genetic testing can sometimes provide more insight into prognosis and helps personalize follow‑up for you and your family. Early symptoms of adrenal gland pheochromocytoma—such as episodic headaches, sweating, and fast heartbeat—can be subtle; catching the condition early and managing blood pressure reduces risks like stroke or heart rhythm problems. Talk with your doctor about what your personal outlook might look like, including how often to test metanephrines, what scans are needed, and which warning signs should prompt a call.
Long-term effects
Most people do well after treatment, especially when the tumor is found early. Even when early symptoms of adrenal gland pheochromocytoma—like pounding headaches or heart racing—settle after surgery, some long-term effects may remain. Long-term effects vary widely. Some live for decades with no return of disease, while others face high blood pressure or tumor recurrence years later.
Blood pressure may stay high even after the tumor is removed. This can raise long-term risks for heart disease and stroke.
Surges of stress hormones can weaken the heart muscle or trigger abnormal rhythms. Some people recover fully, while others have lingering reduced heart function.
Adrenal gland pheochromocytoma can come back months to years later, especially with inherited forms. The chance is higher when diagnosed young or when multiple tumors were present.
A minority develop spread to bone, liver, lungs, or lymph nodes, also called malignant pheochromocytoma. The course can be slow and chronic or more aggressive, affecting survival over time.
How is it to live with Adrenal gland pheochromocytoma?
Living with an adrenal gland pheochromocytoma can feel unpredictable, because hormone surges may trigger sudden pounding headaches, palpitations, sweating, anxiety, and blood pressure spikes that interrupt work, sleep, and everyday plans. Many learn to track triggers, keep medications handy, and coordinate care for monitoring, surgery planning, and follow-up, which can restore stability for most. Family, friends, and coworkers may notice abrupt episodes or emergency visits, so clear communication about what to do during a spell—stay calm, help you sit or lie down, and seek care if symptoms escalate—can make a real difference. With treatment and regular check-ins, many people regain confidence in daily routines, travel, and exercise, even if they remain attentive to warning signs.
Treatment and drugs
Adrenal gland pheochromocytoma is treated by controlling the hormone surge first and then removing the tumor. Treatment often looks different for each person, but most start with blood pressure–lowering medicines that block adrenaline’s effects (alpha-blockers first, sometimes followed by beta-blockers), plus extra fluids and salt to stabilize circulation. Once blood pressure and heart rate are steady—usually over 1–3 weeks—surgeons remove the tumor, most often with minimally invasive (laparoscopic) surgery. If the tumor can’t be fully removed, has spread, or comes back, options can include targeted radiation (such as MIBG), peptide receptor radionuclide therapy, certain chemotherapy combinations, and drugs that target tumor growth pathways. After surgery, regular follow-up with blood and urine tests and imaging helps detect any recurrence and guides long-term care.
Can you cure Adrenal gland pheochromocytoma?
In many people, surgery to remove the adrenal gland tumor (called a pheochromocytoma) can cure it, especially when it hasn’t spread. If the tumor has spread or can’t be fully removed, a cure is less likely, but treatments can control the extra hormones, manage blood pressure and other symptoms, and sometimes slow or shrink the tumor.
Non-drug treatment
Living with adrenal gland pheochromocytoma can make ordinary moments—like climbing stairs or dealing with a stressful call—feel unpredictable because blood pressure or heart rate may surge. Alongside medicines, non-drug therapies can steady daily life and prepare you safely for treatment. Most people ultimately do best with surgery, with carefully planned steps before and after to lower risks. Support for mood, stress, and family screening also matters because some pheochromocytomas run in families.
Removing the tumor is the main non-drug treatment for adrenal gland pheochromocytoma. Many are done with minimally invasive (keyhole) surgery at experienced centers. Your team will tailor the approach based on tumor size, location, and features.
A coordinated plan with surgeons, anesthesia, and endocrinology lowers procedure risks. This includes detailed imaging, cardiovascular checks, and a step-by-step plan for the day of surgery. Ask where the highest-volume center is in your region.
Because many pheochromocytomas are hereditary, counseling helps decide if genetic testing makes sense. Results can guide your care and timing of surgery. They also inform which relatives may need screening.
Home monitoring helps you and your team spot patterns and triggers. Keep a log of readings, symptoms, and what you were doing at the time. Share the log at every visit.
Your genes may have an impact on how drugs work for you
Genes can affect how your body processes medications for adrenal gland pheochromocytoma, changing how well they work and the risk of side effects. For example, differences in drug‑metabolizing genes or tumor mutations may guide choices among alpha‑blockers, beta‑blockers, and anesthesia plans.
Pharmacological treatments
Medicines for adrenal gland pheochromocytoma focus on blocking hormone effects, lowering blood pressure, and preparing safely for surgery. Alpha-blockers are usually started first, with other drugs added to steady heart rate and control symptoms. In advanced or inoperable cases, radiopharmaceuticals, targeted therapies, and chemotherapy can help manage hormones and shrink tumors. Not everyone responds to the same medication in the same way.
Phenoxybenzamine or selective options like doxazosin, prazosin, and terazosin relax blood vessels and lower blood pressure. They’re often started 1–3 weeks before surgery to reduce headaches, pounding heartbeat, and other early symptoms of adrenal gland pheochromocytoma.
Propranolol, metoprolol, or atenolol help control fast or irregular heartbeats. They are added only after adequate alpha blockade to avoid a dangerous spike in blood pressure.
Amlodipine, nifedipine, or intravenous nicardipine can further lower blood pressure or serve as alternatives if alpha blockers aren’t well tolerated. They’re often combined with alpha blockers to smooth blood pressure swings.
This medicine reduces the tumor’s hormone production at its source. It’s added when symptoms remain intense despite alpha blockade or in metastatic disease.
Genetic influences
In adrenal gland pheochromocytoma, genetics play a larger role than many expect: about 30–40% of cases are linked to a gene change present from birth, often inherited. These include well-known syndromes like multiple endocrine neoplasia type 2 (MEN2), von Hippel–Lindau disease, and neurofibromatosis type 1, as well as changes in SDH, MAX, or TMEM127 genes. Having a gene change doesn’t always mean you will develop the condition. The same gene change can affect people differently—some develop tumors earlier, some in both adrenal glands, and certain changes (especially SDHB) carry a higher chance that a tumor may spread. Because of this, genetic testing for adrenal gland pheochromocytoma is often recommended after diagnosis to guide screening for other tumors, tailor follow-up, and inform relatives about their own risk. A strong family history can raise suspicion, but these gene changes can also appear for the first time in someone with no affected relatives, so talking with a genetic counselor can help you decide on next steps.
Is Adrenal gland pheochromocytoma genetic?
Genetics play a major role in adrenal gland pheochromocytoma. About one-third to one-half arise from inherited variants, often in genes like RET, VHL, NF1, and SDHx. Genetic testing is recommended, even without a family history, to guide care and screening.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are found widely in the general population. Most of these variants do not directly affect health and simply reflect normal human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors are involved. In some situations, however, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For adrenal gland pheochromocytoma, inherited gene changes are common and can shape both monitoring and treatment. The tumor’s genes often influence which stress hormones it makes and how strong the blood pressure swings are, which can guide the choice and dosing of pre-surgery alpha and beta blockers to keep you safe. As one example, changes in RET or VHL are linked with adrenaline- or noradrenaline–dominant tumors, while SDHB changes carry a higher chance of spread; knowing this helps plan closer follow-up and when to consider systemic therapy. In advanced disease, genetic information can help match treatments: SDHB-related tumors may respond better to temozolomide or to somatostatin-targeted radiotherapy, and tumors driven by VHL/EPAS1 pathways may be candidates for medicines that block tumor blood-vessel growth. Radiolabeled MIBG therapy depends on the tumor’s ability to take up MIBG on scans, and uptake can vary by gene pattern, so doctors pair imaging results with your genetics when selecting it. Alongside medical history and imaging, genetic testing can help doctors time medicines, tailor blood pressure preparation before surgery, and choose the right systemic option if the tumor spreads. Pharmacogenetic testing for adrenal gland pheochromocytoma usually centers on how your body handles supportive medicines (for example, certain beta blockers), while tumor genetics remains the main driver of therapy choices.
Interactions with other conditions
When adrenal gland pheochromocytoma occurs alongside heart or blood vessel disease, surges of stress hormones can push blood pressure very high, trigger irregular heartbeats, and, in severe cases, strain the heart or raise stroke risk. A condition may “exacerbate” (make worse) symptoms of another, so untreated pheochromocytoma can make existing hypertension brittle and harder to control. It can also disrupt blood sugar; people living with diabetes may notice wider swings and need more insulin until the tumor is treated, and blood sugars often settle after successful surgery. During pregnancy, adrenal gland pheochromocytoma can mimic or intensify preeclampsia with severe headaches and spikes in pressure, so early recognition and coordinated obstetric and endocrine care are vital for parent and baby. Some have pheochromocytoma as part of an inherited syndrome that also increases the chance of other tumors, such as medullary thyroid cancer or growths in the kidneys, eyes, or nerves, which means family history and genetic counseling can guide screening and timing of treatment across conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Adrenal gland pheochromocytoma?
Symptoms like sudden pounding heartbeat, sweating, headaches, and spikes in blood pressure can also come from panic attacks or severe anxiety, an overactive thyroid (hyperthyroidism), menopause hot flashes, heart rhythm problems, or stimulants and certain medicines (such as decongestants or cocaine). Doctors also look for other hormone-related causes of hard-to-control blood pressure—like Cushing’s syndrome (too much cortisol) or primary aldosteronism (too much aldosterone)—as well as kidney artery narrowing, sleep apnea, or common high blood pressure without a tumor.
History
Throughout history, people have described sudden pounding heartbeats, headaches, and sweats that came in waves—episodes that today we recognize can be caused by adrenal gland pheochromocytoma. In older medical records, these “spells” were often blamed on nerves or stress. A person might be told to rest, avoid coffee, or simply live with it, while the true source—a small tumor releasing bursts of stress hormones—remained hidden.
First described in the medical literature as a tumor arising from adrenal “chromaffin” cells in the late 1800s, pheochromocytoma became easier to identify once doctors could measure adrenaline-like hormones in blood and urine during the mid‑20th century. From these first observations, surgeons learned that removing the tumor could bring dramatic relief. Early operations were risky because patients’ blood pressure could surge during surgery; the development of alpha-blocker medicines in the 1950s and 1960s helped stabilize blood pressure beforehand and made surgery safer.
As medical science evolved, imaging changed the story again. Ultrasound, CT scans, and MRI allowed teams to find these tumors before they caused crises. Doctors also realized that some pheochromocytomas sit outside the adrenal glands (paragangliomas), and that not every tumor behaves the same way. This broader view pushed care teams to watch for patterns over time, not just single blood pressure spikes in clinic.
Advances in genetics reshaped understanding in the 1990s and 2000s. Researchers connected pheochromocytoma to inherited conditions such as multiple endocrine neoplasia type 2 (MEN2), von Hippel–Lindau (VHL) syndrome, and changes in SDHx genes, among others. Families and communities once noticed patterns—relatives with early high blood pressure or repeated “adrenaline rushes”—that modern gene testing could finally explain. This shifted care toward screening at‑risk relatives, earlier imaging, and long‑term follow‑up.
In recent decades, awareness has grown that adrenal gland pheochromocytoma can appear at many ages, may be silent for years, and sometimes returns after treatment. International guidelines emerged to standardize testing, prepare patients for surgery, and outline lifelong surveillance. Specialists also refined lab methods, including plasma metanephrines, to catch the condition even when hormone surges are brief.
Over time, the way the condition has been understood has changed, but one thread runs through the history of pheochromocytoma: when the tumor is found and managed with modern testing, careful medication, and skilled surgery, most people see major improvements in symptoms and blood pressure. Today’s approach reflects more than a century of lessons—listening to the story of episodic symptoms, checking for hormone clues, using precise imaging, and, when appropriate, offering genetic counseling to protect both the individual and their family.